The following resources provide examples of TGaS' thought leadership on a variety of pharmaceutical operations and business topics.

Showing 8 out of 80 available documents

Article, Executive Commercial Operations

April 2016

Path to Compelling Payer Value Propositions Subject of New Report


By PharmaVOICE

Effective payer value propositions are among the most pressing issues for biopharmaceutical companies across the board from large tier to startup. “Creating Compelling Payer Value Propositions” is an executive report issued by TGaS Insights, a service providing commercial leaders ...

Research Study, Executive Commercial Operations

March 2016

What Makes More Better? An Exploratory Study on the Effects of Firm-Level Commercial Operations Attributes on Pharmaceutical Business Performance

Journal of Medical Marketing Media

By George A. Chressanthis, Ph.D., Professor of Healthcare Management and Marketing, Fox School of Business and Management, Temple University

Journal of Medical Marketing Publishes Temple Research Funded by TGaS Advisors. A study measuring the impact of pharmaceutical commercial operations on company performance finds that strategic investment in commercial innovation linked with an aligned and responsive culture of ...

Advisory Brief, Executive Commercial Operations

February 2014

Global Commercial Operations Landscape

TGaS® Advisors reaches out to U.S. and Global leaders of commercial operations departments to delve into what appeared to be a trend toward increasing globalization of commercial operations functions and and activities.

White Paper, Executive Commercial Operations

April 2013

Reflections on a Research Study Conducted by the Temple University Fox School of Business

TGaS reflects on the recent independent study conducted by Temple University, "What Aspects of Commercial Operations Impact Pharmaceutical Company Business Performance?"

Article, Executive Commercial Operations

June 2011

Fact vs. Fiction

Pharmaceutical Commerce

Industry observers invariably describe the commercial model as broken. A new TGaS study reveals what's really happening, says Anna McClafferty.

Landscape Study, Executive Commercial Operations

April 2011

The New Commercial Model: Reality or Rhetoric?

TGaS Landscape Study, sorting fact from fiction in this look at the drivers of change and the demands of the new commercial models.

Article, Executive Commercial Operations

July 2010

The Five Things We Need to Do to Re-invent Commercial Operations

Pharmaceutical Commerce

By Stephen Gerard, Chief Executive Officer & Executive Chairman

By running commercial operations like a stand-alone business, executives can sharpen their focus on strategy, tactics and overall performance.

Article, Executive Commercial Operations

November 2008

Pharma Be Nimble. Quick!

Pharmaceutical Executive

TGaS Advisors was part of a select group of 8 consultants asked to share their ideas on the ever-changing environment.

To top